2024 OTS Travel Grant Recipients
Muna Abedrabbo, The University of British ColumbiaUnnur J. Björgvinsdóttir, Technical University of DenmarkMathilde Blitek, U1179 UVSQRut Bryl, UT Southwestern Medical CenterJessica Cale, PhD, Centre for Molecular Medicine and Innovative TherapeuticsMyriam Cerezo-Magaña, PhD, Lund UniversityDavid Cheerie, The Hospital for Sick ChildrenMarguerite Colin, MRC Toxicology Unit, University ...
2024 Patient Advocacy Award
Katie Gross Research Associate, RNA Therapeutics Institute, UMASS Chan Medical School Biography Katie Gross is a Research Associate in the laboratory of Dr. Julia Alterman and Dr. Anastasia Khvorova in the RNA Therapeutics Institute at the University of Massachusetts Chan Medical School. She began ...
2024 Dr. Alan M. Gewirtz Memorial Scholarship – Graduate Students
Jillian Belgrad, M.D./Ph.D. Candidate, MS3/GS4 Khvorova Lab, RNA Therapeutics Institute, UMass Chan Medical School Biography: Jillian Belgrad is a sixth-year MD/PhD student in the RNA Therapeutics Institute at UMass Chan Medical School. Before joining UMass Chan, Jillian graduated from Colgate University with a ...
2024 Dr. Alan M. Gewirtz Memorial Scholarship – Postdoctoral Fellows and Junior Industrial Professionals
Hassan H. Fakih, Ph.D. Post-Doctoral Associate, Prof. Anastasia Khvorova Research Group RNA Therapeutics Institute | UMASS Chan Medical School Biography: Hassan is a Postdoctoral Associate in the lab of Prof. Anastasia Khvorova at the RNA Therapeutics Institute at UMass Chan Medical School. His research focuses on ...
2024 Mary Ann Liebert Publishers Inc., Young Investigator Award
Hélène Tran, Ph.D. Research Director, Head of Antisense Oligonucleotide Therapeutics, Neurology Therapeutic Area, Servier Research Institute, France Biography: Hélène Tran is a Director in the Neuroscience Therapeutic Area at the Servier Research & Development Institute in Paris-Saclay, where she leads the antisense oligonucleotide (ASO) therapeutics ...
2024 Paper of the Year – Basic Research category
Dr. Mikyung Yu, Ph.D. Alnylam Pharmaceuticals Evaluating the oral delivery of GalNAc-conjugated siRNAs in rodents and non-human primates 2024 Paper of the Year – Basic Research category https://pubmed.ncbi.nlm.nih.gov/38742636/ Biography: Mikyung Yu, Ph.D., is a Principal Scientist in Research at Alnylam Pharmaceuticals. Dr. Yu led the ...
The Oligonucleotide Therapeutics Society Announces the 21st Annual Meeting in Budapest, Hungary
The Oligonucleotide Therapeutics Society (OTS) is pleased to announce the 21st Annual OTS Meeting, scheduled for October 19–22, 2025, at the Budapest Congress Center in Budapest, Hungary. This premier global gathering of the oligonucleotide community is renowned for fostering dynamic, cross-disciplinary dialogue—bringing together leaders ...
Genome Sequencing and Gene Editing: Ancient DNA in a Living Species
Known for their large size — sometimes growing up to six feet in length — dark fur and bone-cracking back teeth, dire wolves used to be the most prominent species in continental North America (1). The canines became extinct roughly 10,000 years ago, gradually ...
Strategic IP for Oligonucleotide Therapeutics: Maximizing Innovation Value
Date: August 28, 2025 Time: 11-12pm EDT / 5-6pm CEST Title: Strategic IP for Oligonucleotide Therapeutics: Maximizing Innovation Value Description: This talk will explore the essential elements of an effective IP strategy tailored for oligonucleotide therapeutics, balancing scientific innovation with commercial ...
The importance of involving patients in therapy development; Lessons learned from Duchenne exon skipping
Date: August 21, 2025 Time: 11-12pm EDT / 5-6pm CEST Title: The importance of involving patients in therapy development; Lessons learned from Duchenne exon skipping Description: Duchenne muscular dystrophy is a progressive muscle wasting disease caused by lack of dystrophin protein. ...
